Gujarat has a colorful profile. Gujarat tours are considered best routes for study of Indian heritage and the historic pages of Indian freedom struggle often mentions Gujarat from where Mahatma Gandhi initiated many of his revolts. http://gujarattouristplaces.wordpress.com/ takes you to the era of revolution; however from that age the city has come a long way and today Gujarat is believed to be one of the liveliest cities with multiplexes, amusement parks and several entertainment avenues.
Consumers perceive annuities more positively than financial professionals give them credit for, according to The Future of Retirement Income, a new study released by Genworth.
The study, a culmination of in-depth interviews, focus groups and quantitative surveys with financial professionals, annuity owners and non annuity owners, revealed that 68 percent of non annuity owners have a neutral to positive impression of annuities. For annuity owners, it’s even higher: 91 percent neutral to positive. In addition, the majority of annuity owners are satisfied with access to their account, fees and asset growth.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54358-genworth-financial-pros-underestimate-appeal-of-annuities-among-consumers
Leading scientists have released the latest results of the large scale trials related to nuts consumption and health, particularly in myocardial infarction, stroke and cardiovascular diseases. Recent scientific studies show the benefits of regular intake of nuts, not only associated with cardiovascular health but also with renal function, diabetes, cognitive function, atherosclerosis, metabolic syndrome, inflammatory biomarkers, etc. It is important to highlight that scientific evidence demonstrates that eating nuts is not associated with a higher risk of weight gain, and even reinforce their importance as sources of key nutrients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62432-scientifically-proven-nuts-are-not-fattening
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
The Art Institutes and Americans for the Arts, the nation's leading nonprofit organization for advancing the arts and arts education, announced today that entries for the 2013 Poster Design Competition will be accepted through January 31, 2013. The Competition winners will earn tuition scholarships to study at one of the more than 50 Art Institutes schools, including a full tuition scholarship for the national first place winner in the high school senior category.
To view Multimedia News Release, go to http://www.multivu.com/players/English/58518-art-institutes-2013-poster-design-competition/
mark. Brand Ambassador Ashley Greene joined advocates on Capitol Hill in Washington, D.C. for a congressional briefing to announce data from the “NO MORE Study: Teens and Young Adults,” funded by m.powerment by mark., managed by the Avon Foundation for Women. The results of the study – which explored attitudes toward, and experience with dating abuse, partner violence, and sexual assault among teens and young adults – clearly underscore the need to educate young people so they recognize the signs of abuse and how to safely intervene to help end it.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60624-avon-mark-and-ashley-greene-no-more-campaign-dating-abuse-study-results
ADP®, a leading provider of employee health care benefits administration and human capital management (HCM) services, today announced the findings of a new ADP Research Institutes (SM) study indicating that if 2012 health benefit participation rate patterns persist into next year, then a portion of newly eligible employees may opt to remain uninsured because they perceive the cost of insurance is too significant a percentage of their annual income.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60557-adp-research-institute-study-employee-health-benefits-participation
check out our new website: www.972kravmaga.com
The Krav Maga In No Time home study video course consists of 27 high quality HD format videos teaching you how to react and get out unharmed from a violence situation. You will learn to use the natural movements of your body to defend yourself and move to a counterattack.
ADP®, a leading provider of employee healthcare benefits administration services and human capital management (HCM) services, today announced the findings of an ADP Research InstituteSM study based on actual, real-world data for approximately one million employees and more than two million covered lives. The ADP 2012 Study of Large Employer Health Benefits found that part-time workers eligible for health care benefits at large companies in the United States elect coverage at a significantly lower rate than full-time employees.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60219-adp-research-institute-2012-study-of-large-employer-health-benefits
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
Concerns about the cost of a divorce weigh heavily on the minds of people facing a divorce, including whether or not to hire an attorney, and in the decision of who to hire, according to a new Avvo Divorce Study*. Fifty-eight percent of individuals without children cite cost as their top concern going into the divorce ahead of concerns about property division (42 percent), time the divorce will take (27 percent) or alimony (22 percent). For individuals with children, cost is second to custody concerns (53 percent vs. 35 percent), but it remained the top factor cited as to why they ultimately chose to hire their specific attorney.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61093-avvo-divorce-study-top-concern-cost
